Correlation Between Regenxbio and Denali Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Regenxbio and Denali Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regenxbio and Denali Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Regenxbio and Denali Therapeutics, you can compare the effects of market volatilities on Regenxbio and Denali Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regenxbio with a short position of Denali Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regenxbio and Denali Therapeutics.

Diversification Opportunities for Regenxbio and Denali Therapeutics

0.48
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Regenxbio and Denali is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding Regenxbio and Denali Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Denali Therapeutics and Regenxbio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regenxbio are associated (or correlated) with Denali Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Denali Therapeutics has no effect on the direction of Regenxbio i.e., Regenxbio and Denali Therapeutics go up and down completely randomly.

Pair Corralation between Regenxbio and Denali Therapeutics

Given the investment horizon of 90 days Regenxbio is expected to under-perform the Denali Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Regenxbio is 1.01 times less risky than Denali Therapeutics. The stock trades about -0.02 of its potential returns per unit of risk. The Denali Therapeutics is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  2,051  in Denali Therapeutics on September 6, 2024 and sell it today you would earn a total of  319.00  from holding Denali Therapeutics or generate 15.55% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy99.66%
ValuesDaily Returns

Regenxbio  vs.  Denali Therapeutics

 Performance 
       Timeline  
Regenxbio 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Regenxbio has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Denali Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Denali Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong essential indicators, Denali Therapeutics is not utilizing all of its potentials. The latest stock price confusion, may contribute to short-horizon losses for the traders.

Regenxbio and Denali Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Regenxbio and Denali Therapeutics

The main advantage of trading using opposite Regenxbio and Denali Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regenxbio position performs unexpectedly, Denali Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Denali Therapeutics will offset losses from the drop in Denali Therapeutics' long position.
The idea behind Regenxbio and Denali Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Other Complementary Tools

Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume